Private equity firm GTCR announced today that Corza Medical acquired Katena Products and its ophthalmic surgery offerings.
Katena develops ophthalmic products used across cataract, glaucoma and corneal surgeries, including precision surgical instruments, single-use devices and specialty biologics, according to a news release. The company, which has more than 200 employees across North America and Europe, has sold products in more than 110 countries to more than 5,000 customers.
Corza said in the release that the acquisition expands its surgical product portfolio while adding significant scale, product breadth and infrastructure to its ophthalmic surgery segment. It’s the first add-on acquisition for Corza since its formation in January 2021, with the company aiming to take on the “almost monopolistic” leaders in medtech. Corza was formed through the merger of Surgical Specialties and TachoSil, a carve-out from Takeda.
R…